Verve Therapeutics, Inc.

CIK 1840574 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Verve Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2025SCHEDULE 13G/A0000921895-25-002286
Aug 14, 2025SCHEDULE 13G0000902664-25-003639
Aug 4, 202515-12G0001193125-25-172180
Jul 28, 202540000950170-25-099258
Jul 28, 202540000950170-25-099262
Jul 28, 202540000950170-25-099257
Jul 28, 202540000950170-25-099261
Jul 28, 202540000950170-25-099260
Jul 28, 2025SCHEDULE 13G/A0001415889-25-020385
Jul 28, 202540000950170-25-099264
Jul 28, 202540000950170-25-099259
Jul 28, 202540000950170-25-099255
Jul 28, 202540000950170-25-099253
Jul 28, 2025EFFECT9999999995-25-002366
Jul 28, 202540000950170-25-099256
Jul 28, 202540000950170-25-099263
Jul 28, 202540001415889-25-020384
Jul 28, 202540000950170-25-099251
Jul 28, 202540000950170-25-099254
Jul 28, 202540000950170-25-099252
Jul 25, 2025S-8 POS0001193125-25-165134
Jul 25, 2025POSASR0001193125-25-165139
Jul 25, 20258-K0001193125-25-165462
Jul 25, 2025S-8 POS0001193125-25-165135
Jul 25, 2025S-8 POS0001193125-25-165124